140410 — Mezzion Pharma Co Cashflow Statement

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMid CapMomentum Trap

Annual cashflow statement for Mezzion Pharma Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	—	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	-23,251	-13,829	-13,509	-36,298	-12,728
Depreciation
Non-Cash Items	2,985	7,949	-738	16,345	-1,353
Unusual Items
Other Non-Cash Items
Changes in Working Capital	-1,945	-2,928	-2,411	6,220	1,512
Change in Accounts Receivable
Change in Inventories
Change in Other Assets
Change in Accounts Payable
Change in Other Liabilities
Net Change in Other Assets & Liabilities
Other Operating Cash Flow
Cash from Operating Activities	-20,880	-7,377	-15,071	-12,075	-11,023
Capital Expenditures	-1,098	-7,956	-6,183	-1,761	-11,858
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items	1,403	11,518	-10,151	19,171	-13,697
Sale of Fixed Assets
Sale/Maturity of Investment
Change in Net Investments
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities	304	3,561	-16,334	17,410	-25,555
Financing Cash Flow Items	—	—	20,000	—	—
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities	6,762	24,008	19,112	-616	47,214
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	-13,907	20,210	-11,644	5,189	10,847